Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals Inc. et al
Plaintiff: Novartis Pharmaceuticals Corporation and Novartis AG
Defendant: Teva Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Case Number: 1:2024cv00428
Filed: April 4, 2024
Court: US District Court for the District of Delaware
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on April 4, 2024. A more recent docket listing may be available from PACER.

Date Filed Document Text
April 4, 2024 Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis AG, Novartis Pharmaceuticals Corporation. (oam)
April 4, 2024 Filing 5 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,061,029. (oam)
April 4, 2024 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,163,904; 8,293,756; 8,389,537; 8,415,363 ; 8,501,760. (oam)
April 4, 2024 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/20/2024. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/20/2026. (oam)
April 4, 2024 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam)
April 4, 2024 Filing 1 COMPLAINT filed for PATENT INFRINGEMENT against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals Inc., Teva Pharmaceuticals USA, Inc. ( Filing fee $ 405, receipt number ADEDC-4377436.) - filed by Novartis Pharmaceuticals Corporation, Novartis AG. (Attachments: #1 Exhibit A-F, #2 Civil Cover Sheet)(oam)
April 4, 2024 No Summons Issued. (oam)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Novartis Pharmaceuticals Corporation et al v. Teva Pharmaceuticals Inc. et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis Pharmaceuticals Corporation
Represented By: Daniel M. Silver
Represented By: Alexandra M. Joyce
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Novartis AG
Represented By: Daniel M. Silver
Represented By: Alexandra M. Joyce
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceuticals USA, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Teva Pharmaceutical Industries Ltd.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?